Vor Biopharma VOR Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $396.49M+384% | $81.95M+161% | $31.36M-45.7% | $57.71M-51.8% | ||
| $58.72M+489% | $9.98M-90.6% | $105.82M-38.7% | $172.54M+96.8% | ||
| $7.91M-51.4% | $16.28M-4.3% | $17.02M-19.7% | $21.2M+15.4% | ||
| $458.11M+375% | $96.51M-31.5% | $140.8M-40.6% | $236.95M+10.5% | ||
| $533K-91.9% | $6.58M-34.5% | $10.05M-20.5% | $12.63M+84.4% | ||
| $2.94M-91.6% | $35.01M-12.6% | $40.05M-9.9% | $44.44M+184% | ||
| $2.38M0.0% | $2.38M-50.5% | $4.81M+64.5% | $2.93M-10.1% | ||
| $464.13M+225% | $142.89M-27.9% | $198.13M-33.8% | $299.37M+23.4% | ||
| $5.13M+241% | $1.51M+84.7% | $815K-54.0% | $1.77M+14.7% | ||
| $19.76M+53.3% | $12.89M+25,684% | $50K-73.1% | $186K-57.1% | ||
| $280K-93.4% | $4.22M+10.1% | $3.83M+17.1% | $3.27M+77.9% | ||
| $25.17M+35.2% | $18.61M+19.5% | $15.57M+18.7% | $13.12M+29.2% | ||
| $2.72M-90.2% | $27.62M-13.2% | $31.83M-10.7% | $35.64M+120% | ||
| $3M-90.6% | $31.83M-10.7% | $35.66M-8.4% | $38.91M+116% | ||
| $628.44M+1,259% | $46.23M-2.5% | $47.4M-2.8% | $48.76M+85.2% | ||
| $18K+38.5% | $13K+85.7% | $7K0.0% | $7K+75.0% | ||
| $988.6M+78.6% | $553.62M+12.8% | $490.87M+3.7% | $473.59M+36.7% | ||
| -$1.15B-152% | -$456.99M-34.4% | -$340.08M-53.0% | -$222.22M-70.8% | ||
| $41K+86.4% | $22K+129% | -$77K+90.0% | -$770K— | ||
| -$164.31M-70.0% | -$96.66M-164% | $150.72M-39.9% | $250.61M+15.9% | ||
| $464.13M+225% | $142.89M-27.9% | $198.13M-33.8% | $299.37M+23.4% | ||
| $58.72M+489% | $9.98M-90.6% | $105.82M-38.7% | $172.54M+96.8% | ||
| $1.75M+359% | $380K-20.0% | $475K-79.7% | $2.34M+11.6% | ||
| $2.38M0.0% | $2.38M-50.5% | $4.81M+64.5% | $2.93M-10.1% | ||
| $2.94M-91.6% | $35.01M-12.6% | $40.05M-9.9% | $44.44M+184% | ||
| $2.94M-91.6% | $35.01M-12.6% | $40.05M-9.9% | $44.44M+184% | ||
| $2.38M0.0% | $2.38M-50.5% | $4.81M+64.5% | $2.93M-10.1% | ||
| $2.94M-91.6% | $35.01M-12.6% | $40.05M-9.9% | $44.44M+184% | ||
| $2.38M0.0% | $2.38M-50.5% | $4.81M+64.5% | $2.93M-10.1% | ||
| $19.76M+53.3% | $12.89M+18.5% | $10.88M+37.9% | $7.89M+24.5% | ||
| $19.76M+53.3% | $12.89M+18.5% | $10.88M+37.9% | $7.89M+24.5% | ||
| $3M-90.6% | $31.83M-10.7% | $35.66M-8.4% | $38.91M+116% | ||
| $988.6M+78.6% | $553.62M+12.8% | $490.87M+3.7% | $473.59M+36.7% | ||
| $18K+38.5% | $13K+85.7% | $7K0.0% | $7K+75.0% | ||
| $1.15M-72.6% | $4.2M+33.2% | $3.15M-27.8% | $4.37M-9.7% | ||
| $168K-93.0% | $2.41M0.0% | $2.41M0.0% | $2.41M0.0% | ||
| $600.55M— | $0— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Vor Biopharma's total assets?
- Vor Biopharma (VOR) holds $506.7M in total assets, up 363.6% year over year.
- How much debt does Vor Biopharma have?
- Vor Biopharma carries $2.9M in total debt against -$150.4M of shareholders' equity, a debt-to-equity ratio of 0.47.
- How much cash does Vor Biopharma have?
- Vor Biopharma holds $169.9M in cash and equivalents.
- Can Vor Biopharma cover its short-term obligations?
- Its current ratio is 31.15 — current assets exceed current liabilities.
- Where does Vor Biopharma's balance sheet data come from?
- Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.